DK1317256T3 - Farmaceutisk sammensætning havende en modificeret bærer - Google Patents
Farmaceutisk sammensætning havende en modificeret bærerInfo
- Publication number
- DK1317256T3 DK1317256T3 DK01968045T DK01968045T DK1317256T3 DK 1317256 T3 DK1317256 T3 DK 1317256T3 DK 01968045 T DK01968045 T DK 01968045T DK 01968045 T DK01968045 T DK 01968045T DK 1317256 T3 DK1317256 T3 DK 1317256T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- modified carrier
- carrier
- modified
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23176700P | 2000-09-12 | 2000-09-12 | |
| PCT/US2001/026013 WO2002022107A2 (en) | 2000-09-12 | 2001-09-07 | Pharmaceutical composition having modified carrier |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1317256T3 true DK1317256T3 (da) | 2009-01-26 |
Family
ID=22870572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01968045T DK1317256T3 (da) | 2000-09-12 | 2001-09-07 | Farmaceutisk sammensætning havende en modificeret bærer |
Country Status (18)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040033938A1 (en) * | 2000-09-12 | 2004-02-19 | Britten Nancy J. | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| KR20040015622A (ko) * | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물 |
| US7659061B2 (en) * | 2002-11-19 | 2010-02-09 | Pharmacia & Upjohn Company | Pharmaceutical compositions having a modified vehicle |
| US20080153894A1 (en) * | 2002-12-19 | 2008-06-26 | Pharmacia Corporation | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| JP5685193B2 (ja) * | 2008-11-19 | 2015-03-18 | メリアル リミテッド | セフチオフルおよびケトプロフェンとまたはセフチオフルとベンジルアルコールとを含む製剤 |
| BRPI0903778B1 (pt) | 2009-07-17 | 2017-04-18 | Cargill Agrícola S A | composição alimentícia de gordura vegetal, processo de preparação de uma composição alimentícia de gordura vegetal e uso de uma composição alimentícia de gordura vegetal na preparação de recheio |
| CN103957888B (zh) * | 2011-09-29 | 2017-11-21 | PLx 制药公司 | 用于将药物沿胃肠道靶向释放的pH依赖性载体、其组合物及其制备和应用 |
| CA2968320A1 (en) | 2014-11-19 | 2016-05-26 | Cassandra K JONES | Chemical mitigants in animal feed and feed ingredients |
| MA55205A (fr) | 2019-03-06 | 2022-01-12 | Zoetis Services Llc | Formulations injectables prêtes à l'emploi |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU222244B1 (hu) * | 1993-03-12 | 2003-05-28 | Pharmacia & Upjohn Co. | Szabad sav formájában lévő kristályos ceftiofur, ennek előállítása és ezt tartalmazó gyógyászati készítmény |
| US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
| US6074657A (en) * | 1997-03-20 | 2000-06-13 | Pharmacia & Upjohn Company | Administration of an injectable antibiotic in the ear of an animal |
-
2001
- 2001-09-07 MX MXPA03002055A patent/MXPA03002055A/es unknown
- 2001-09-07 ES ES01968045T patent/ES2313981T3/es not_active Expired - Lifetime
- 2001-09-07 US US09/948,827 patent/US20020110561A1/en not_active Abandoned
- 2001-09-07 WO PCT/US2001/026013 patent/WO2002022107A2/en active IP Right Grant
- 2001-09-07 NZ NZ524694A patent/NZ524694A/en unknown
- 2001-09-07 DK DK01968045T patent/DK1317256T3/da active
- 2001-09-07 DE DE60136367T patent/DE60136367D1/de not_active Expired - Lifetime
- 2001-09-07 JP JP2002526359A patent/JP4738713B2/ja not_active Expired - Lifetime
- 2001-09-07 AU AU8832301A patent/AU8832301A/xx active Pending
- 2001-09-07 EP EP01968045A patent/EP1317256B1/en not_active Expired - Lifetime
- 2001-09-07 BR BRPI0113372A patent/BRPI0113372B8/pt active IP Right Grant
- 2001-09-07 PT PT01968045T patent/PT1317256E/pt unknown
- 2001-09-07 AU AU2001288323A patent/AU2001288323B2/en not_active Expired
- 2001-09-07 AT AT01968045T patent/ATE412405T1/de not_active IP Right Cessation
- 2001-09-07 CA CA2416566A patent/CA2416566C/en not_active Expired - Lifetime
- 2001-09-11 AR ARP010104286A patent/AR030648A1/es not_active Application Discontinuation
- 2001-09-11 PE PE2001000912A patent/PE20030046A1/es not_active Application Discontinuation
- 2001-09-12 TW TW090122605A patent/TWI284046B/zh not_active IP Right Cessation
-
2003
- 2003-01-22 ZA ZA200300617A patent/ZA200300617B/en unknown
-
2012
- 2012-06-06 AR ARP120101998A patent/AR086688A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0113372B8 (pt) | 2021-10-13 |
| ZA200300617B (en) | 2004-04-22 |
| WO2002022107A3 (en) | 2003-01-16 |
| JP2004508395A (ja) | 2004-03-18 |
| MXPA03002055A (es) | 2004-12-13 |
| BRPI0113372B1 (pt) | 2017-08-01 |
| JP4738713B2 (ja) | 2011-08-03 |
| EP1317256A2 (en) | 2003-06-11 |
| DE60136367D1 (de) | 2008-12-11 |
| AU2001288323B2 (en) | 2006-11-23 |
| CA2416566A1 (en) | 2002-03-21 |
| US20020110561A1 (en) | 2002-08-15 |
| PE20030046A1 (es) | 2003-02-14 |
| NZ524694A (en) | 2005-05-27 |
| EP1317256B1 (en) | 2008-10-29 |
| ATE412405T1 (de) | 2008-11-15 |
| WO2002022107A2 (en) | 2002-03-21 |
| BR0113372A (pt) | 2003-06-24 |
| PT1317256E (pt) | 2008-12-17 |
| AU8832301A (en) | 2002-03-26 |
| AR030648A1 (es) | 2003-08-27 |
| BRPI0113372A8 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2003-06-24 |
| CA2416566C (en) | 2011-05-31 |
| AR086688A2 (es) | 2014-01-15 |
| TWI284046B (en) | 2007-07-21 |
| ES2313981T3 (es) | 2009-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1524266T3 (da) | Farmaceutisk sammensætning | |
| NO20015175D0 (no) | Farmasöytisk sammensetning | |
| FI991485L (fi) | Uusi farmaseuttinen koostumus | |
| AR028204A1 (es) | Composiciones farmaceuticas electrohiladas | |
| FI20105657L (fi) | Farmaseuttisia koostumuksia | |
| NO20002571L (no) | Emballasje | |
| ITMI20010748A0 (it) | Composizioni farmaceutiche | |
| EE200200526A (et) | Kapslid | |
| ATE330937T1 (de) | Glyburid-zusammensetzung | |
| ATE388040T1 (de) | Träger | |
| NO20024431D0 (no) | Kapsler | |
| NO20026123L (no) | Farmasöytiske sammensetninger | |
| DE60016836D1 (de) | Resistzusammensetzung | |
| NO20014926D0 (no) | Farmasöytiske forbindelser | |
| ATE366128T1 (de) | Pharmazeutische zusammensetzung | |
| DE60037421D1 (de) | Stopfbuchspackung | |
| FI5176U1 (fi) | Sitalopraamia sisältävä farmaseuttinen koostumus | |
| DK1317256T3 (da) | Farmaceutisk sammensætning havende en modificeret bærer | |
| PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
| FI4488U1 (fi) | Farmaseuttinen koostumus | |
| DE60037420D1 (de) | Stopfbuchspackung | |
| EE200300378A (et) | Farmatseutiline kompositsioon | |
| EE200200689A (et) | Ravimkoostised | |
| DE60001712D1 (de) | Etikettiervorrichtung | |
| SE9904819D0 (sv) | A new pharmaceutical composition |